arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

PMGC Holdings Inc.

ELAB
$4.56 ▲ +0.28 (+6.54%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
5 Visible periods
22 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

PMGC Holdings Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin
ROIC
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

5-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$590.08K
↓ -65.5%
Net Income Profit after all expenses
$-7.75M
↓ -24.0%
FCF / Share Free cash flow per share
$-0.42
↓ -154.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality
56

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 5 years · 19 quarters